149 related articles for article (PubMed ID: 28687332)
21. Identification of Novel Biomarkers for Metastatic Colorectal Cancer Using Angiogenesis-Antibody Array and Intracellular Signaling Array.
Chung S; Dwabe S; Elshimali Y; Sukhija H; Aroh C; Vadgama JV
PLoS One; 2015; 10(8):e0134948. PubMed ID: 26258407
[TBL] [Abstract][Full Text] [Related]
22. Dual epidermal growth factor receptor (EGFR)/insulin-like growth factor-1 receptor (IGF-1R) inhibitor: a novel approach for overcoming resistance in anticancer treatment.
Tandon R; Kapoor S; Vali S; Senthil V; Nithya D; Venkataramanan R; Sharma A; Talwadkar A; Ray A; Bhatnagar PK; Dastidar SG
Eur J Pharmacol; 2011 Sep; 667(1-3):56-65. PubMed ID: 21640718
[TBL] [Abstract][Full Text] [Related]
23. Insulin-like growth factor-1 induces lymphangiogenesis and facilitates lymphatic metastasis in colorectal cancer.
Li ZJ; Ying XJ; Chen HL; Ye PJ; Chen ZL; Li G; Jiang HF; Liu J; Zhou SZ
World J Gastroenterol; 2013 Nov; 19(43):7788-94. PubMed ID: 24282367
[TBL] [Abstract][Full Text] [Related]
24. Impact of IGF-1R/EGFR cross-talks on hepatoma cell sensitivity to gefitinib.
Desbois-Mouthon C; Cacheux W; Blivet-Van Eggelpoël MJ; Barbu V; Fartoux L; Poupon R; Housset C; Rosmorduc O
Int J Cancer; 2006 Dec; 119(11):2557-66. PubMed ID: 16988945
[TBL] [Abstract][Full Text] [Related]
25. ATM mutations and E-cadherin expression define sensitivity to EGFR-targeted therapy in colorectal cancer.
Geißler AL; Geißler M; Kottmann D; Lutz L; Fichter CD; Fritsch R; Weddeling B; Makowiec F; Werner M; Lassmann S
Oncotarget; 2017 Mar; 8(10):17164-17190. PubMed ID: 28199979
[TBL] [Abstract][Full Text] [Related]
26. Correlation of clinicopathological parameters with HGF, c-Met, EGFR, and IGF-1R expression in uveal melanoma.
Topcu-Yilmaz P; Kiratli H; Saglam A; Söylemezoglu F; Hascelik G
Melanoma Res; 2010 Apr; 20(2):126-32. PubMed ID: 20061986
[TBL] [Abstract][Full Text] [Related]
27. Expression of IGF-1R in colorectal polyps and its role in colorectal carcinogenesis.
Shan HB; Zhang R; Li Y; Xu GL; Luo GY; Gao XY; Yang HL
Technol Cancer Res Treat; 2011 Aug; 10(4):381-9. PubMed ID: 21728395
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Yamada R; Fujii S; Rino Y; Kunisaki C; Tanaka K; Masuda M; Imada T
Oncol Rep; 2008 Aug; 20(2):359-64. PubMed ID: 18636198
[TBL] [Abstract][Full Text] [Related]
29. Insulin-like growth factor receptor-1 overexpression is associated with poor response of rectal cancers to radiotherapy.
Wu XY; Wu ZF; Cao QH; Chen C; Chen ZW; Xu Z; Li WS; Liu FK; Yao XQ; Li G
World J Gastroenterol; 2014 Nov; 20(43):16268-74. PubMed ID: 25473182
[TBL] [Abstract][Full Text] [Related]
30. Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial.
Sclafani F; Kim TY; Cunningham D; Kim TW; Tabernero J; Schmoll HJ; Roh JK; Kim SY; Park YS; Guren TK; Hawkes E; Clarke SJ; Ferry D; Frodin JE; Ayers M; Nebozhyn M; Peckitt C; Loboda A; Watkins DJ
Int J Cancer; 2017 Jan; 140(2):431-439. PubMed ID: 27681944
[TBL] [Abstract][Full Text] [Related]
31. IGF-1R, IGF-1 and IGF-2 expression as potential prognostic and predictive markers in colorectal-cancer.
Peters G; Gongoll S; Langner C; Mengel M; Piso P; Klempnauer J; Rüschoff J; Kreipe H; von Wasielewski R
Virchows Arch; 2003 Aug; 443(2):139-45. PubMed ID: 12845531
[TBL] [Abstract][Full Text] [Related]
32. Sensitivity of breast cancer cell lines to the novel insulin-like growth factor-1 receptor (IGF-1R) inhibitor NVP-AEW541 is dependent on the level of IRS-1 expression.
Mukohara T; Shimada H; Ogasawara N; Wanikawa R; Shimomura M; Nakatsura T; Ishii G; Park JO; Jänne PA; Saijo N; Minami H
Cancer Lett; 2009 Sep; 282(1):14-24. PubMed ID: 19345478
[TBL] [Abstract][Full Text] [Related]
33. Blockade of IGF-1 receptor tyrosine kinase has antineoplastic effects in hepatocellular carcinoma cells.
Höpfner M; Huether A; Sutter AP; Baradari V; Schuppan D; Scherübl H
Biochem Pharmacol; 2006 May; 71(10):1435-48. PubMed ID: 16530734
[TBL] [Abstract][Full Text] [Related]
34. Simultaneous inhibition of IGF1R and EGFR enhances the efficacy of standard treatment for colorectal cancer by the impairment of DNA repair and the induction of cell death.
Oberthür R; Seemann H; Gehrig J; Rave-Fränk M; Bremmer F; Halpape R; Conradi LC; Scharf JG; Burfeind P; Kaulfuß S
Cancer Lett; 2017 Oct; 407():93-105. PubMed ID: 28823963
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of insulin-like growth factor-1 receptor enhances eribulin-induced DNA damage in colorectal cancer.
Yoshihiro T; Ariyama H; Yamaguchi K; Imajima T; Yamaga S; Tsuchihashi K; Isobe T; Kusaba H; Akashi K; Baba E
Cancer Sci; 2022 Dec; 113(12):4207-4218. PubMed ID: 36053154
[TBL] [Abstract][Full Text] [Related]
36. Xanthoceraside induces apoptosis in melanoma cells through the activation of caspases and the suppression of the IGF-1R/Raf/MEK/ERK signaling pathway.
Jiao Q; Zou L; Liu P; Xu Q; Zhang Y; Yu Y; Zou L; Chi T; Ji X
J Med Food; 2014 Oct; 17(10):1070-8. PubMed ID: 25116791
[TBL] [Abstract][Full Text] [Related]
37. The insulin-like growth factor receptor 1 is a promising target for novel treatment approaches in neuroendocrine gastrointestinal tumours.
Höpfner M; Baradari V; Huether A; Schöfl C; Scherübl H
Endocr Relat Cancer; 2006 Mar; 13(1):135-49. PubMed ID: 16601284
[TBL] [Abstract][Full Text] [Related]
38. Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition.
Dallas NA; Xia L; Fan F; Gray MJ; Gaur P; van Buren G; Samuel S; Kim MP; Lim SJ; Ellis LM
Cancer Res; 2009 Mar; 69(5):1951-7. PubMed ID: 19244128
[TBL] [Abstract][Full Text] [Related]
39. EGFR and IGF-1R in regulation of prostate cancer cell phenotype and polarity: opposing functions and modulation by T-cadherin.
Maslova K; Kyriakakis E; Pfaff D; Frachet A; Frismantiene A; Bubendorf L; Ruiz C; Vlajnic T; Erne P; Resink TJ; Philippova M
FASEB J; 2015 Feb; 29(2):494-507. PubMed ID: 25381040
[TBL] [Abstract][Full Text] [Related]
40. Gefitinib resistance in HCC mahlavu cells: upregulation of CD133 expression, activation of IGF-1R signaling pathway, and enhancement of IGF-1R nuclear translocation.
Bodzin AS; Wei Z; Hurtt R; Gu T; Doria C
J Cell Physiol; 2012 Jul; 227(7):2947-52. PubMed ID: 21959795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
